Finance

Lists
EXPO:NASDAQ
Exponent Inc
$67.46
-0.56%
(-0.38) 1D
Aug 5, 10:34:16 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EXPO...
Open
$68.45
High
$68.45
Low
$66.87
Mkt. cap
3.28B
Avg. vol.
588.32K
Volume
32.15K
Dividend
1.84%
Quarterly dividend
$0.31
Ex-dividend date
Jun 5, 2026
P/E ratio
31.48
52-wk high
$81.92
52-wk low
$51.91
EPS
$2.14
Beta
0.69
Shares outstanding
48.51M
No. of employees
1K
Open
$68.45
High
$68.45
Low
$66.87
Mkt. cap
3.28B
Avg. vol.
588.32K
Volume
32.15K
Dividend
1.84%
Quarterly dividend
$0.31
Ex-dividend date
Jun 5, 2026
P/E ratio
31.48
52-wk high
$81.92
52-wk low
$51.91
EPS
$2.14
Beta
0.69
Shares outstanding
48.51M
No. of employees
1K
News stories
From sources across the web
Profile
Exponent, Inc. is an American engineering and scientific consulting firm. Exponent has a team of scientists, physicians, engineers, and business consultants which performs research and analysis in more than 90 technical disciplines. The company operates 20 offices in the United States and five offices overseas. Wikipedia
About Exponent Inc
CEOCatherine Ford Corrigan
Employees1.01K
FoundedApr 1967
HeadquartersMenlo Park, California, United States
SectorService
Analyst ratings
Based on 4 analysts giving stock ratings to EXPO in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for EXPO in the last 3 months.
Highest
Current $67.46
$90.00 (+33.41%)
Average
$84.00 (+24.52%)
Lowest
$72.00 (+6.73%)
Analyst
Recommendation
Action
Price target
Projected
Date
Tomohiko Sano
J.P. Morgan
Buy
Maintained
$90.00
+33.4%
08/04/2026
Tobey Sommer
Truist Financial
Buy
Reiterated
$90.00
+33.4%
07/31/2026
Joshua Chan
UBS
Hold
Reiterated
$72.00
+6.7%
07/31/2026
Andrew Nicholas
William Blair
Buy
Reiterated
-
-
07/31/2026
Last report
Jul 30, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$0.60 / $0.60
+0.43%beat
Revenue / Est. (USD)
148.86M / 147.49M
+0.93%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
137.07M
129.38M
151.82M
148.86M
Cost of goods sold
87.73M
80.89M
91.41M
100.57M
Cost of revenue
87.73M
80.89M
91.41M
100.57M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.56M
10.53M
10.30M
7.40M
Operating expense
20.31M
19.35M
19.03M
20.27M
Total operating expenses
108.04M
100.24M
110.44M
120.84M
Operating income
29.04M
29.14M
41.38M
28.02M
Other non operating income
7.27M
3.19M
-758.00K
12.03M
EBT including unusual items
38.62M
34.10M
42.34M
40.77M
EBT excluding unusual items
38.62M
34.10M
42.34M
40.77M
Income tax expense
10.57M
9.34M
12.77M
11.37M
Effective tax rate
27.38%
27.39%
30.16%
27.89%
Other operating expenses
8.75M
8.82M
8.73M
12.86M
Net income
28.04M
24.76M
29.57M
29.40M
Net profit margin
20.46%
19.14%
19.48%
19.75%
Earnings per share
0.55
0.49
0.59
0.60
Interest and investment income
2.31M
1.94M
1.72M
716.00K
Interest expense
-
-
-
-
Net interest expenses
2.31M
1.94M
1.72M
716.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
31.57M
31.68M
43.89M
30.54M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps